跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
INVEGA 9 MG COMPRIMIDOS DE LIBERACION PROLONGADA - CIMA-AEMPS Drug Approval Details
Approvals
/
CIMA-AEMPS
/
INVEGA 9 MG COMPRIMIDOS DE LIBERACION PROLONGADA
Approved
STANDARD
INVEGA 9 MG COMPRIMIDOS DE LIBERACION PROLONGADA
Janssen-Cilag International N.V
🇪🇸 Spanish Agency of Medicines and Medical Devices
Approval Date
Mar 24, 2025
Approval ID
7b2fc8b40a338916
Company
Janssen-Cilag International N.V
Type
Standard
Approval Details
Approval Id
7b2fc8b40a338916
Drug Cima Aemps Name
INVEGA 9 MG COMPRIMIDOS DE LIBERACION PROLONGADA
Register Number
107395049IP1
Holder Company Name
Janssen-Cilag International N.V
Marketing Company Name
Melyfarma S.L.
Holder Company Detail Path
/organization/janssen-cilag-international-nv
Authorization Date
2025-03-24
Dosage Form
COMPRIMIDO DE LIBERACIÓN PROLONGADA
Dose
9 mg
Route Of Administration
VÍA ORAL
Prescription Type
Medicamento Sujeto A Prescripción Médica
Commercialized
Yes
Company Name
Janssen-Cilag International N.V
Company Detail Path
/organization/janssen-cilag-international-nv
Company Information
Pharmaceutical Company Name
Janssen-Cilag International NV
Country Name
Belgium
Approved
Quick Info
Agency
CIMA-AEMPS
Country
🇪🇸
Approval Date
Mar 24, 2025
Approval ID
7b2fc8b40a338916
Type
Standard
Back to CIMA-AEMPS Approvals
